Search

Your search keyword '"Canonica, Giorgio"' showing total 2,323 results

Search Constraints

Start Over You searched for: Author "Canonica, Giorgio" Remove constraint Author: "Canonica, Giorgio"
2,323 results on '"Canonica, Giorgio"'

Search Results

3. Exploring Definitions and Predictors of Response to Biologics for Severe Asthma

4. Profiling severe asthma: Any relevance for age? An analysis from Severe Asthma Network Italy (SANI) cohort

5. International Variation in Severe Exacerbation Rates in Patients With Severe Asthma

12. Long-term effectiveness of benralizumab in severe eosinophilic asthma patients treated for 96-weeks: data from the ANANKE study

14. Efficacy and safety of ligelizumab in adults and adolescents with chronic spontaneous urticaria: results of two phase 3 randomised controlled trials

15. Intranasal Versus Oral Treatments for Allergic Rhinitis: A Systematic Review With Meta-Analysis

17. Analysis of comorbidities and multimorbidity in adult patients in the International Severe Asthma Registry

19. Severe Asthma Network Italy Definition of Clinical Remission in Severe Asthma: A Delphi Consensus

21. Impact of Initiating Biologics in Patients With Severe Asthma on Long-Term Oral Corticosteroids or Frequent Rescue Steroids (GLITTER): Data From the International Severe Asthma Registry

25. Severe Asthma Standard-of-Care Background Medication Reduction With Benralizumab: ANDHI in Practice Substudy

29. Nasal cytology as a reliable non-invasive procedure to phenotype patients with type 2 chronic rhinosinusitis with nasal polyps

33. WAO-ARIA consensus on chronic cough – Part III: Management strategies in primary and cough-specialty care. Updates inCOVID-19

34. Effectiveness and safety of dupilumab in patients with chronic rhinosinusitis with nasal polyps and associated comorbidities: a multicentric prospective study in real life

36. ChAracterization of ItaliaN severe uncontrolled Asthmatic patieNts Key features when receiving Benralizumab in a real-life setting: the observational rEtrospective ANANKE study

40. Why fexofenadine is considered as a truly non-sedating antihistamine with no brain penetration: a systematic review.

41. SANI Clinical Remission definition: a useful tool in Severe Asthma management.

42. WAO-ARIA consensus on chronic cough - Part II: Phenotypes and mechanisms of abnormal cough presentation — Updates inCOVID-19

43. WAO-ARIA consensus on chronic cough – Part 1: Role of TRP channels in neurogenic inflammation of cough neuronal pathways

44. Exploring the Potential Role of Metabolomics in COPD: A Concise Review

45. Sustained Effectiveness of Benralizumab in Naïve and Biologics-Experienced Severe Eosinophilic Asthma Patients: Results from the ANANKE Study

47. Unlocking the Long-Term Effectiveness of Benralizumab in Severe Eosinophilic Asthma: A Three-Year Real-Life Study

48. Reply to “Exploring the long-term effects of biologic initiation in severe asthma: Insights from the International Severe Asthma Registry”

49. Long-Term Efficacy Of Dupilumab In Patients With Moderate-To-Severe Type 2 Asthma Stratified By Baseline Characteristics During The 96-Week TRAVERSE Study

50. Association Of Baseline Lung Function And Likelihood Of Oral Corticosteroid Reduction In Patients With OCS-Dependent Severe Asthma

Catalog

Books, media, physical & digital resources